BARRESI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.671
EU - Europa 2.507
AS - Asia 616
AF - Africa 134
OC - Oceania 26
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.961
Nazione #
US - Stati Uniti d'America 3.513
IT - Italia 1.224
SE - Svezia 351
CN - Cina 295
DE - Germania 248
BG - Bulgaria 179
AT - Austria 174
CA - Canada 154
SG - Singapore 90
GB - Regno Unito 80
VN - Vietnam 72
FR - Francia 66
JP - Giappone 54
RU - Federazione Russa 52
CI - Costa d'Avorio 51
IN - India 40
NG - Nigeria 39
SN - Senegal 37
FI - Finlandia 34
HK - Hong Kong 32
BE - Belgio 27
AU - Australia 26
UA - Ucraina 20
TR - Turchia 17
PL - Polonia 12
NL - Olanda 8
CZ - Repubblica Ceca 6
EG - Egitto 6
CH - Svizzera 5
BR - Brasile 4
HU - Ungheria 4
RO - Romania 4
KR - Corea 3
TW - Taiwan 3
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
HR - Croazia 2
IR - Iran 2
MX - Messico 2
PK - Pakistan 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
Totale 6.961
Città #
Serra 560
Woodbridge 393
Fairfield 363
Ann Arbor 343
Chandler 332
Houston 302
Ashburn 256
Sofia 179
Seattle 168
Vienna 156
Ottawa 146
New York 144
Wilmington 130
Beijing 118
Princeton 109
Cambridge 105
Frankfurt am Main 91
Lawrence 78
Medford 73
Des Moines 70
Milan 70
Abidjan 51
Dearborn 47
Pisa 47
Rho 41
Bremen 40
Lagos 39
Dakar 37
London 37
Nanjing 31
Hong Kong 28
Brussels 27
Dong Ket 25
Los Angeles 24
San Jose 24
Florence 23
Sydney 22
Boulder 20
Pessac 19
Ogden 18
San Diego 18
Pune 16
Izmir 15
Jacksonville 15
Cascina 14
Pistoia 13
Redwood City 13
Alessandria 12
Changsha 12
Hefei 12
Rome 12
Aversa 11
Kunming 11
Shenyang 11
Vercelli 11
Nanchang 10
Santa Margherita Ligure 10
Talence 10
Lancaster 9
Livorno 9
Vicopisano 9
Warsaw 9
Jiaxing 8
Norwalk 8
Toronto 8
Auburn Hills 7
Gif-sur-yvette 7
Hebei 7
Nürnberg 7
Tianjin 7
Arezzo 6
Citta 6
Council Bluffs 6
Helsinki 6
Kyoto 6
Phoenix 6
Singapore 6
Falls Church 5
Garbagnate Milanese 5
Hangzhou 5
Lucca 5
Paris 5
Prague 5
Scafati 5
Amsterdam 4
Boardman 4
Cairo 4
Castelnuovo di Garfagnana 4
Dortmund 4
Edinburgh 4
Guangzhou 4
Jinan 4
Marseille 4
Salerno 4
San Giuliano Terme 4
Tokyo 4
Viareggio 4
Budapest 3
Caserta 3
Central 3
Totale 5.245
Nome #
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 249
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 213
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 197
Allosteric modulators of human A2B adenosine receptor. 177
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 176
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 164
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 161
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 157
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 157
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 148
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 146
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 142
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 132
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 132
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 130
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 128
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 127
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 122
An update into the medicinal chemistry of translocator protein (TSPO) ligands 119
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 108
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 108
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 106
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 106
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 104
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 104
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 103
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 99
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 98
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 97
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 96
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 96
Structure-Activity Relationship Refinement and Further Assessment of 4-Phenylquinazoline-2-carboxamide Translocator Protein Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 94
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 92
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 86
Glioblastoma multiforme: induction of mitochondria-mediated apoptotic pathway by simultaneous pharmacological activation of TSPO (18KDa) and p53. 82
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 81
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 81
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 80
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 76
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 75
Carbonic anhydrase activation profile of indole-based derivatives 74
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 73
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 72
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 72
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 71
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications 70
Design and synthesis of novel indolylglyoxylamide derivatives as molecular probes for 18 KDa translocator protein (TSPO) 68
Interaction of the irreversible ligand IRDE-MPIGA with TSPO (18 KDa): new insight on TSPO role in tumor cells. 67
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 66
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 65
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 64
null 63
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 62
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 62
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 61
Development of a New A2B Adenosine Receptors PET ligand: 3- Phenyl-1-[11C]methyl-3- aryl[1,2,4]triazino[4,3 -a]benzimidazol-4(10H)-one 57
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 56
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 55
Strategies for the improvement of metal-based chemotherapeutic treatments 50
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 49
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 49
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 48
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 48
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 46
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 46
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 46
Development of novel indole-based tdp1 inhibitors for anticancer therapy 45
Labeling of TSPO PET radioligands by [18F]fluorination of diarylsulfoxide precursors 45
Modulation of PAR1 signaling by benzimidazole compounds 41
Targeting the KRAS oncogene: Synthesis, physicochemical and biological evaluation of novel G-Quadruplex DNA binders 40
Translocator Protein 18-kDa: a promising target to treat neuroinflammation-related degenerative diseases 40
Radiosynthesis of the TSPO 18 kDa PET Radiotracer [18F](R)-PK14105 39
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides. 39
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 37
Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging 36
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 32
H2S-releasing properties of new thioamide derivatives 32
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 29
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 28
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 28
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 25
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 24
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 23
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 19
Toward PET imaging of A2B adenosine receptors: A carbon-11 labeled triazinobenzimidazole tracer. Synthesis and imaging of a new A2B PET tracer 19
Enriching the arsenal of pharmacological tools against mical2 18
Allosteric Modulators of Adenosine Receptors 16
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties 15
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 14
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 10
null 9
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 8
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 6
Metformin conjugates and therapeutic use thereof 2
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview 1
Totale 7.229
Categoria #
all - tutte 18.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019168 0 0 0 0 0 0 0 0 0 0 99 69
2019/20201.300 111 66 351 61 91 122 117 96 106 68 90 21
2020/2021728 145 62 53 12 55 24 14 61 90 63 50 99
2021/20221.037 41 91 53 39 137 166 55 46 34 34 45 296
2022/20231.532 162 207 127 146 151 190 14 97 324 13 71 30
2023/2024976 59 72 104 40 119 249 129 44 11 30 119 0
Totale 7.229